Orient International Enterprise, Ltd. (SHA:600278)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,798	6,136	6,163	6,052	7,026	7,512
Market Cap Growth	5.07%	-0.44%	1.83%	-13.86%	-6.47%	35.58%
Enterprise Value	3,903	2,876	2,379	3,196	4,575	4,621
Last Close Price	7.75	6.92	6.71	6.49	7.51	7.93
PE Ratio	32.29	28.37	22.65	16.38	18.45	27.02
PS Ratio	0.19	0.17	0.18	0.15	0.16	0.18
PB Ratio	0.86	0.78	0.80	0.81	0.97	1.01
P/TBV Ratio	0.94	0.84	0.88	0.89	1.06	1.10
P/FCF Ratio	-	-	23.30	6.80	-	-
P/OCF Ratio	-	-	19.78	6.38	54.69	59.78
EV/Sales Ratio	0.11	0.08	0.07	0.08	0.11	0.11
EV/EBITDA Ratio	10.12	9.86	5.75	3.90	8.63	14.13
EV/EBIT Ratio	16.33	15.28	8.03	4.59	11.44	21.39
EV/FCF Ratio	-6.44	-	8.99	3.59	-	-
Debt / Equity Ratio	0.13	0.11	0.08	0.13	0.21	0.15
Debt / EBITDA Ratio	2.59	2.52	1.30	1.12	2.65	3.48
Debt / FCF Ratio	-	-	2.28	1.10	-	-
Asset Turnover	1.93	1.97	1.86	2.22	2.40	2.47
Inventory Turnover	15.76	21.48	16.62	17.48	22.35	23.98
Quick Ratio	0.89	0.98	1.00	0.78	0.79	0.88
Current Ratio	1.39	1.40	1.47	1.35	1.33	1.42
Return on Equity (ROE)	3.50%	3.62%	4.96%	6.50%	6.30%	5.17%
Return on Assets (ROA)	0.82%	0.65%	1.02%	2.32%	1.38%	0.79%
Return on Capital (ROIC)	1.73%	1.38%	2.21%	5.05%	2.88%	1.79%
Return on Capital Employed (ROCE)	2.80%	2.20%	3.60%	8.80%	5.10%	2.70%
Earnings Yield	3.11%	3.52%	4.42%	6.11%	5.42%	3.70%
FCF Yield	-8.92%	-4.67%	4.29%	14.71%	-2.53%	-0.80%
Dividend Yield	2.23%	2.41%	1.39%	1.94%	1.73%	1.17%
Payout Ratio	92.33%	92.31%	53.06%	42.56%	34.70%	64.48%
Buyback Yield / Dilution	-2.26%	1.46%	0.23%	-1.67%	-15.16%	1.31%
Total Shareholder Return	-0.02%	3.87%	1.61%	0.28%	-13.43%	2.48%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.